References
  1. Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576–1583.
  2. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933–1940.
  3. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877–883.
  4. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882–1890.
  5. Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008;359:1009–1017.
  6. Sweeney MO, Sherfesee L, DeGroot PJ, Wathen MS, Wilkoff BL. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 2010;7:353–360.
  7. Wathen MS, DeGroot PJ, Sweeney MO, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 2004;110:2591–2596.
  8. Anguera I, Dallaglio P, Martínez-Ferrer J, et al. Shock reduction with multiple bursts of antitachycardia pacing therapies to treat fast ventricular tachyarrhythmia in patients with implantable cardioverter defibrillators: A multicenter study. J Cardiovasc Electrophysiol 2015;26:774–782.
  9. Sanders P, Connolly AT, Nabutovsky Y, Fischer A, Saeed M. Increased hospitalizations and overall healthcare utilization in patients receiving implantable cardioverter-defibrillator shocks compared with antitachycardia pacing. J Am Coll Cardiol EP 2018;4:243–253.
  10. Gulizia MM, Piraino L, Scherillo M, et al. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmia in patients with implantable cardioverter defibrillators: The PITAGORA ICD trial. Circ Arrhythm Electrophysiol 2009;2:146–153.
  11. Fang Y, Gu K, Yang B, et al. What factors lead to the acceleration of ventricular tachycardia during antitachycardia pacing?-Results from over 1000 episodes. J Arrhythm 2017;34:36–45.
  12. Garcia-Alberola A, Yli-Mäyry S, Block M, et al. RR interval variability in irregular monomorphic ventricular tachycardia and atrial fibrillation. Circulation 1996;93:295–300.
  13. Oginosawa Y, Kohno R, Honda T, et al. Superior rhythm discrimination with the SmartShock technology algorithm - results of the implantable Defibrillator With Enhanced Features and Settings for Reduction of Inaccurate Detection (DEFENSE) Trial. Circ J 2017;81:1272–1277.
  14. Duncker D, Veltmann C. Optimizing antitachycardia pacing: back to the roots. Circ Arrhythm Electrophysiol 2017;10: number 9.
  15. Riley MP, Marchlinski FE. ECG clues for diagnosing ventricular tachycardia mechanism. J Cardiovasc Electrophysiol 2008;19:224-229.
  16. Jiménez-Candil J, Hernández J, Martin A, et al. Influence of cycle length variations on antitachycardia pacing effectiveness among ICD patients. Heart Rhythm 2013;10:207–213.
  17. Tuan TC, Lo MT, Lin YJ, et al. The use of signal analyses of ventricular tachycardia electrograms to predict the response of antitachycardia pacing in patients with implantable cardioverter-defibrillators. J Cardiovasc Electrophysiol 2014;25:411–417.
  18. Cronin EM, Bogun FM, Maury P, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Heart Rhythm 2020;17:e2–154.
  19. Joung B, Lexcen DR, Ching CK, et al. Additional antitachycardia pacing programming strategies further reduce unnecessary implantable cardioverter-defibrillator shocks. Heart Rhythm 2020; 7:98–105.
  20. Cantillon DJ, Wilkoff BL. Antitachycardia pacing for reduction of implantable cardioverter-defibrillator shocks. Heart Rhythm 2015;12:1370–1375.
  21. Josephson M. Evaluation of electrical therapy for arrhythmias. In: Josephson M, editor. Clinical Cardiac Electrophysiology. Philadelphia, PA: Lippincott Williams & Wilkins, 2008:701.
  22. Moak JP, Rosen MR. Induction and termination of triggered activity by pacing in isolated canine Purkinje fibers. Circulation 1984;69:149–162.
  23. Kumar S, Romero J, Mehta NK, et al. Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease. Heart Rhythm 2016;13:1957–1963.